Report cover image

APAC Sarcopenia Treatment Market - Industry Trends and Forecast to 2031

Publisher Data Bridge Market Research
Published Oct 01, 2023
Length 241 Pages
SKU # DAABD18360519

Description

APAC Sarcopenia Treatment Market - Industry Trends and Forecast to 2031


The Asia-Pacific sarcopenia treatment market is expected to reach USD 861,882.42 thousand by 2030 from USD 547,450.80 thousand in 2022, growing at a CAGR of 5.9% in the forecast period of 2023 to 2030
Market Segmentation
Asia-Pacific Sarcopenia Treatment Market, By Treatment Type (Medications, Vitamin/Dietary Supplements, and Others), Type (Primary Sarcopenia and Secondary Sarcopenia), Stages (Pre-Sarcopenia, Sarcopenia, and Severe Sarcopenia), Route Of Administration (Oral, Injectable, and Others), Gender (Male and Female), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Taiwan, And Rest Of Asia-Pacific) - Industry Trends and Forecast to 2030

Overview of Asia-Pacific Sarcopenia Treatment Market Dynamics

Driver
• Rising prevalence of sarcopenia

Restrain

• Lack of standardized diagnosis

Opportunity

• Strategic initiatives by key market players

Market Players

Some of the key market players operating in the Asia-Pacific sarcopenia treatment market are listed below:
• Abbott
• Nestlé Health Science (A subsidiary of Nestlé S.A.)
• Novartis AG
• Sanofi
• Haleon Group of Companies
• BASF SE
• DSM
• Fermenta Biotech Limited
• AstaReal Co., Ltd.
• Metagenics
• Wellona Pharma
• The Vitamin Company India
• Healing Pharma India Pvt. Ltd
• Others

Table of Contents

241 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Asia - Pacific Sarcopenia Treatment Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Treatment Type Segment Lifeline Curve
2.8 Market End User Coverage Grid
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces Model
4.3 Current Status Of Emerging Drugs For Sarcopenia Treatment
5 Asia - Pacific Sarcopenia Treatment Market: Regulations
5.1 Regulations In U.S.
5.2 Regulations In Europe
5.3 Regulations In Australia
5.4 Regulations In South Africa 56 
6 Market Overview
6.1 Drivers
6.1.1 Rising Prevalence Of Sarcopenia
6.1.2 Growing Awareness Of Sarcopenia And Its Detrimental Effects On Health
6.1.3 Lifestyle Factors Such As Poor Nutrition And Sedentary Behaviour
6.2 Restraints
6.2.1 Lack Of Standardized Diagnosis
6.2.2 High Cost Of Treatment And Interventions
6.3 Opportunities
6.3.1 Strategic Initiatives By Market Players
6.3.2 Increasing Research And Development Activities
6.4 Challenges
6.4.1 Complications Associated With The Sarcopenia Treatment
6.4.2 Stringent Government Rules And Regulation For Product Approval
7 Asia - Pacific Sarcopenia Treatment Market, By Treatment Type
7.1 Overview
7.2 Vitamin/Dietary Supplements
7.2.1 Vitamin Supplements
7.2.2 Protein Supplements
7.2.3 Fatty Acid Supplements
7.2.4 Creatine
7.2.5 Whey Proteins
7.2.6 L-carnitine
7.2.7 Soy
7.2.8 Beta-alanine
7.2.9 Ostarine
7.2.10 Collagen Peptides
7.2.11 Ligandrol
7.2.12 Branch-chain Amino Acids
7.2.13 Hydroxymethylbutyrate (Hmb)
7.2.14 Medium Chain Triglycerides
7.2.15 Others 71 
7.3 Medications
7.3.1 Off Label Drugs
7.3.2 Emerging Drugs
7.3.2.1 Ace Inhibitors
7.3.2.2 Appetite Stimulants
7.3.2.3 Oral Antidiabetic Drugs
7.3.2.4 Others
7.4 Others
8 Asia - Pacific Sarcopenia Treatment Market, By Type
8.1 Overview
8.2 Primary Sarcopenia
8.2.1 Vitamin/Dietary Supplements
8.2.2 Medications
8.2.3 Others
8.3 Secondary Sarcopenia
8.3.1 Vitamin/Dietary Supplements
8.3.2 Medications
8.3.3 Others
9 Asia - Pacific Sarcopenia Treatment Market, By Stages
9.1 Overview
9.2 Pre-sarcopenia
9.3 Sarcopenia
9.4 Severe Sarcopenia
10 Asia - Pacific Sarcopenia Treatment Market, By Route Of Administration
10.1 Overview
10.2 Oral
10.3 Injectables
10.4 Others
11 Asia - Pacific Sarcopenia Treatment Market, By Gender
11.1 Overview
11.2 Male
11.3 Female 96 
12 Asia - Pacific Sarcopenia Treatment Market, By End User
12.1 Overview
12.2 Hospitals
12.2.1 Public
12.2.2 Private
12.3 Specialty Clinics
12.4 Home Healthcare
12.5 Others
13 Asia - Pacific Sarcopenia Treatment Market, By Distribution Channel
13.1 Overview
13.2 Direct Tender
13.3 Retail Sales
13.3.1 Hospital Pharmacies
13.3.2 Online Pharmacies
13.3.3 Others
13.4 Others
14 Asia - Pacific Sarcopenia Treatment Market, By Region
14.1 Asia-pacific
14.1.1 Japan
14.1.2 China
14.1.3 South Korea
14.1.4 India
14.1.5 Australia
14.1.6 Singapore
14.1.7 Thailand
14.1.8 Malaysia
14.1.9 Indonesia
14.1.10 Philippines
14.1.11 Vietnam
14.1.12 New Zealand
14.1.13 Taiwan
14.1.14 Rest Of Asia-pacific
15 Asia - Pacific Sarcopenia Treatment Market, Company Landscape
15.1 Company Share Analysis: Asia - Pacific
16 Swot Analysis 201 
17 Company Profile
17.1 Abbott
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Development
17.2 Nestlé Health Science (A Subsidiary Of Nestlé S.A.)
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development
17.3 Novartis Ag
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Pipeline Portfolio
17.3.6 Recent Development
17.4 Sanofi
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Haleon Group Of Companies.
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Development
17.6 Astareal Co., Ltd.
17.6.1 Company Snapshot
17.6.2 Product Portfolio
17.6.3 Recent Development 212 
17.7 Basf Se
17.7.1 Company Snapshot
17.7.2 Revenue Analysis
17.7.3 Product Portfolio
17.7.4 Recent Development
17.8 Biogen Sa
17.8.1 Company Snapshot
17.8.2 Product Portfolio
17.8.3 Recent Development
17.9 Biothrive Sciences
17.9.1 Company Snapshot
17.9.2 Product Portfolio
17.9.3 Recent Development
17.10 Dsm
17.10.1 Company Snapshot
17.10.2 Revenue Analysis
17.10.3 Product Portfolio
17.10.4 Recent Development
17.11 Fermenta Biotech Limited
17.11.1 Company Snapshot
17.11.2 Revenue Analysis
17.11.3 Product Portfolio
17.11.4 Recent Development
17.12 Healing Pharma India Pvt. Ltd.
17.12.1 Company Snapshot
17.12.2 Product Portfolio
17.12.3 Recent Development
17.13 Metagenics
17.13.1 Company Snapshot
17.13.2 Product Portfolio
17.13.3 Recent Development
17.14 The Vitamin Company India
17.14.1 Company Snapshot
17.14.2 Product Portfolio
17.14.3 Recent Development
17.15 Wellona Pharma
17.15.1 Company Snapshot
17.15.2 Product Portfolio
17.15.3 Recent Development 224 
17.16 Armgo Pharma, Inc.
17.16.1 Company Snapshot
17.16.2 Pipeline Portfolio
17.16.3 Recent Development
17.17 Biophytis
17.17.1 Company Snapshot
17.17.2 Pipeline Portfolio
17.17.3 Recent Development
17.18 Dystrogen Therapeutics Corp
17.18.1 Company Snapshot
17.18.2 Pipeline Portfolio
17.18.3 Recent Development
17.19 Immunoforge Inc.
17.19.1 Company Snapshot
17.19.2 Pipeline Portfolio
17.19.3 Recent Development
17.20 Mymd Pharmaceuticals
17.20.1 Company Snapshot
17.20.2 Pipeline Portfolio
17.20.3 Recent Development
17.21 Nmd Pharma A/S
17.21.1 Company Snapshot
17.21.2 Pipeline Portfolio
17.21.3 Recent Development
17.22 Oncocross Co., Ltd.
17.22.1 Company Snapshot
17.22.2 Pipeline Portfolio
17.22.3 Recent Development
17.23 Opko Health, Inc.
17.23.1 Company Snapshot
17.23.2 Revenue Analysis
17.23.3 Pipeline Portfolio
17.23.4 Recent Development
17.24 Regeneron Pharmaceuticals Inc.
17.24.1 Company Snapshot
17.24.2 Revenue Analysis
17.24.3 Pipeline Portfolio
17.24.4 Recent Development 235 
17.25 Rejuvenate Biomed Nv
17.25.1 Company Snapshot
17.25.2 Pipeline Portfolio
17.25.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 Current Status Of The Development Of Drug For Sarcopenia Treatment
Table 2 Asia - Pacific Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 3 Asia - Pacific Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 4 Asia - Pacific Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 5 Asia - Pacific Medications In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 6 Asia - Pacific Medicatinons In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 7 Asia - Pacific Off-lable Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 8 Asia - Pacific Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 9 Asia - Pacific Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 10 Asia - Pacific Primary Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 11 Asia - Pacific Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 12 Asia - Pacific Secondary Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 13 Asia - Pacific Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 14 Asia - Pacific Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 15 Asia - Pacific Pre-sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 16 Asia - Pacific Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 17 Asia - Pacific Severe Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 18 Asia - Pacific Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 19 Asia - Pacific Oral In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 20 Asia - Pacific Injectables In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 21 Asia - Pacific Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 22 Asia - Pacific Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 23 Asia - Pacific Male In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 24 Asia - Pacific Female In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 25 Asia - Pacific Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 26 Asia - Pacific Hospitals In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 27 Asia - Pacific Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 28 Asia - Pacific Specialty Clinics In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 29 Asia - Pacific Home Healthcare In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 30 Asia - Pacific Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 31 Asia - Pacific Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 32 Asia - Pacific Direct Tender In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 33 Asia - Pacific Retail Sales In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 34 Asia - Pacific Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 35 Asia - Pacific Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand)
Table 36 Asia-pacific Sarcopenia Treatment Market, By Country, 2021-2030 (Usd Thousand)
Table 37 Asia-pacific Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 38 Asia-pacific Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 39 Asia-pacific Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 40 Asia-pacific Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 41 Asia-pacific Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 42 Asia-pacific Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 43 Asia-pacific Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 44 Asia-pacific Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 45 Asia-pacific Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 46 Asia-pacific Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 47 Asia-pacific Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 48 Asia-pacific Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 49 Asia-pacific Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 50 Asia-pacific Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 51 Asia-pacific Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 52 Japan Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 53 Japan Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 54 Japan Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 55 Japan Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 56 Japan Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 57 Japan Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 58 Japan Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 59 Japan Primary Sarcopenia In Sarcopeniatreatment Market, By Type, 2021-2030 (Usd Thousand)
Table 60 Japan Secondary Sarcopenia In Sarcopeniatreatment Market, By Type, 2021-2030 (Usd Thousand)
Table 61 Japan Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 62 Japan Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 63 Japan Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 64 Japan Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 65 Japan Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 66 Japan Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 67 Japan Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 68 China Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 69 China Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 70 China Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 71 China Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 72 China Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 73 China Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 74 China Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 75 China Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 76 China Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 77 China Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 78 China Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 79 China Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 80 China Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 81 China Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 82 China Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 83 China Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 84 South Korea Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 85 South Korea Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 86 South Korea Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 87 South Korea Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 88 South Korea Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 89 South Korea Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 90 South Korea Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 91 South Korea Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 92 South Korea Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 93 South Korea Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 94 South Korea Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 95 South Korea Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 96 South Korea Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 97 South Korea Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 98 South Korea Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 99 South Korea Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 100 India Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 101 India Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 102 India Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 103 India Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 104 India Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 105 India Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 106 India Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 107 India Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 108 India Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 109 India Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 110 India Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 111 India Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 112 India Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 113 India Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 114 India Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 115 India Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 116 Australia Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 117 Australia Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 118 Australia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 119 Australia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 120 Australia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 121 Australia Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 122 Australia Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 123 Australia Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 124 Australia Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 125 Australia Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 126 Australia Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 127 Australia Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 128 Australia Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 129 Australia Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 130 Australia Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 131 Australia Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 132 Singapore Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 133 Singapore Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 134 Singapore Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 135 Singapore Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume)
Table 136 Singapore Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp)
Table 137 Singapore Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 138 Singapore Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 139 Singapore Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 140 Singapore Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 141 Singapore Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand)
Table 142 Singapore Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
Table 143 Singapore Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand)
Table 144 Singapore Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand)
Table 145 Singapore Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
Table 146 Singapore Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 147 Singapore Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
Table 148 Thailand Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
Table 149 Thailand Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 Asia - Pacific Sarcopenia Treatment Market: Segmentation
Figure 2 Asia - Pacific Sarcopenia Treatment Market: Data Triangulation
Figure 3 Asia - Pacific Sarcopenia Treatment Market: Droc Analysis
Figure 4 Asia - Pacific Sarcopenia Treatment Market: Asia - Pacific Vs Regional Market Analysis
Figure 5 Asia - Pacific Sarcopenia Treatment Market: Company Research Analysis
Figure 6 Asia - Pacific Sarcopenia Treatment Market: Interview Demographics
Figure 7 Asia - Pacific Sarcopenia Treatment Market: Market End Users Coverage Grid
Figure 8 Asia - Pacific Sarcopenia Treatment Market: Dbmr Market Position Grid
Figure 9 Asia - Pacific Sarcopenia Treatment Market: Vendor Share Analysis
Figure 10 Asia - Pacific Sarcopenia Treatment Market: Segmentation
Figure 11 The Rising Prevalence Of Sarcopenia And Growing Awareness Of Sarcoepnia And Its Detrimental Effect On Health Are Expected To Drive The Growth Of The Asia - Pacific Sarcopenia Treatment Market From 2023 To 2030
Figure 12 Vitamin/Dietary Supplements Segment Is Expected To Account For The Largest Share Of The Asia - Pacific Preclinical Market In 2023 And 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Asia - Pacific Sarcopenia Treatment Market
Figure 14 Asia - Pacific Sarcopenia Treatment Market: By Treatment Type, 2022
Figure 15 Asia - Pacific Sarcopenia Treatment Market: By Treatment Type, 2023-2030 (Usd Thousand)
Figure 16 Asia - Pacific Sarcopenia Treatment Market: By Treatment Type, Cagr (2023-2030)
Figure 17 Asia - Pacific Sarcopenia Treatment Market: By Treatment, Lifeline Curve
Figure 18 Asia - Pacific Sarcopenia Treatment Market: By Type, 2022
Figure 19 Asia - Pacific Sarcopenia Treatment Market: By Type, 2023-2030 (Usd Thousand)
Figure 20 Asia - Pacific Sarcopenia Treatment Market: By Type, Cagr (2023-2030)
Figure 21 Asia - Pacific Sarcopenia Treatment Market: By Type, Lifeline Curve
Figure 22 Asia - Pacific Sarcopenia Treatment Market: By Stages, 2022
Figure 23 Asia - Pacific Sarcopenia Treatment Market: By Stages, 2023-2030 (Usd Thousand)
Figure 24 Asia - Pacific Sarcopenia Treatment Market: By Stages, Cagr (2023-2030)
Figure 25 Asia - Pacific Sarcopenia Treatment Market: By Stages, Lifeline Curve
Figure 26 Asia - Pacific Sarcopenia Treatment Market: By Route Of Administration, 2022
Figure 27 Asia - Pacific Sarcopenia Treatment Market: By Route Of Administration (2023-2030)
Figure 28 Asia - Pacific Sarcopenia Treatment Market: By Route Of Administration (2023-2030)
Figure 29 Asia - Pacific Sarcopenia Treatment Market: Lifeline Curve
Figure 30 Asia - Pacific Sarcopenia Treatment Market: By Gender, 2022
Figure 31 Asia - Pacific Sarcopenia Treatment Market: By Gender, 2023-2030 (Usd Thousand)
Figure 32 Asia - Pacific Sarcopenia Treatment Market: By Gender, Cagr (2023-2030)
Figure 33 Asia - Pacific Sarcopenia Treatment Market: By Gender, Lifeline Curve
Figure 34 Asia - Pacific Sarcopenia Treatment Market: By End User, 2022
Figure 35 Asia - Pacific Sarcopenia Treatment Market: By End User, 2023-2030 (Usd Thousand)
Figure 36 Asia - Pacific Sarcopenia Treatment Market: By End User, Cagr (2023-2030)
Figure 37 Asia - Pacific Sarcopenia Treatment Market: By End User, Lifeline Curve
Figure 38 Asia - Pacific Sarcopenia Treatment Market: By Distribution Channel, 2022
Figure 39 Asia - Pacific Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 40 Asia - Pacific Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 41 Asia - Pacific Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
Figure 42 Asia - Pacific Sarcopenia Treatment Market: Snapshot (2022)
Figure 43 Asia - Pacific Sarcopenia Treatment Marketstructural Health Monitoring Market: Company Share 2022 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us